News Agency
Men's Weekly

Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma

  • Written by PR Newswire
Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma

Highlights

  • Cohort 2 completed in participants with neuroblastoma who received therapy with 67Cu SARTATE™ at a dose of 175MBq/kg body weight
  • No Dose Limiting Toxicities (DLTs) have been reported in cohort 1 and cohort 2
  • Safety Review Committee (SRC) has recommended the trial continues with the dose escalation phase as planned
  • Recruitment of...

Read more: Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma

Aligning Social, Email, and Web Campaigns with Structured Content: Building a Unified Marketing Engine

Few modern marketing campaigns exist in a bubble. A product launch, for example, may kick off with social media buzz, continue into a targeted email campaign, and finish with a conversion-focused web experience. Ideally, all three touchpoints communicate the same... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion